Spending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicines increased by 11.1% in March 2022 compared to March 2021 (+18.6% over the 12 months April 2021 to March 2022 versus the previous 12 months). Expenditure on retail drugs increased 12.3% on account of increased spending on high-cost treatments and expenses linked to the COVID-19 pandemic, while spending on rétrocession drugs (ie hospital drugs which can be dispensed by hospital pharmacies to hospital out-patients and charged to the patient’s health insurer rather than the hospital) fell 0.2%.
Spending on out-patient care rose 5.9% in March 2022 compared to March 2021. Expenditure on consultations with general practitioners (GPs) and specialists increased by 1.9% and 3.3%, respectively, over the same time period. Spending on public hospitals meanwhile grew by 17.6% in March 2022 versus March 2021 while spending on private hospitals grew 12.8%.
www.ameli.fr, “Remboursements de soins à fin mars 2022”, 26th April 2022